TIMELY-PrädiktoR Prospective Study
1 other identifier
observational
1,200
1 country
1
Brief Summary
Brief Summary: Cardiac rehabilitation (CR) is a multi-factorial intervention, designed to limit the physiological and psychological effects of cardiovascular disease such as coronary artery disease (CAD), manage symptoms, and reduce the risk of future cardiovascular events. CR is a structured program not only addressing CAD but also comorbidities including hypertension, dyslipidemia, diabetes and obesity as well as other risk factors. CR aims at long-term lifestyle changes to reduce modifiable risk factors, and it's success depends on a large number of interacting variables including biological, psychological and social factors. Recently, the importance of patient-centered approaches to secondary prevention and CR success has been underlined but intra-individual factors and their interactions are not well understood. The TIMELY prospective study aims to collect high-resolution data for data mining and artificial intelligence machine learning models to identify dependencies between factors and predict favorable outcomes of CR. Data collection will include data documented during controlled center-based CR as well as remote-measurement of physical activity data, (central) blood pressure and pulse wave analysis as well as long-term ECG data during a 6-months period after discharge. Follow-up assessments will be performed at least at 6 months and at 12 months after discharge. Events (MACCE) will be collected for up to 10 years. After 2023, the study will be run under the acronym PrädiktoR. Main objectives of the study:
- 1.To examine uptake and adherence to a healthy lifestyle (i. e. adherence to CR guidelines in CAD) and the effects on long-term outcomes.
- 2.To identify potentially mediating mechanisms and predictive factors for long-term CR success in CAD, also to be used in machine learning models and for the generation of digital twins.
- 3.To investigate acceptance of different eHealth components as well as expectations and needs among CAD patents in CR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 13, 2022
CompletedFirst Posted
Study publicly available on registry
July 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2029
March 30, 2026
March 1, 2026
8.3 years
July 13, 2022
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Cardiorespiratory Fitness (CRF)
CRF will be measured as maximal oxygen uptake (VO2max) determined by spiroergometry
Baseline, week 3, week 24, and week 48
Change in risk of mortality
Risk of mortality will be determined using the validated biomarker risk score COROPREDICT
Baseline, week 3, week 24, and week 48
Number of patients with major adverse cardiac and cerebrovascular events (MACCE)
Number of patients with death, myocardial infarction, stent thrombosis, stroke or transient ischemic attack, urgent revascularization, and major bleeding
Baseline to week 48, and week 432
Secondary Outcomes (36)
Physical activity (PA)
Baseline, week 3, week 24, and week 48
Daily step count
Baseline to week 24
Weekly number and duration of physical activities
Baseline to week 24
Resting heart rate
Baseline to week 24
Sleep duration
Baseline to week 24
- +31 more secondary outcomes
Other Outcomes (1)
Needs and requirements for eHealth in cardiac rehabilitation
Week 3
Study Arms (1)
Coronary Artery Disease
Patients with Coronary Artery Disease
Eligibility Criteria
Coronary Artery Disease (CAD) patients participating in phase II Cardiac Rehabilitation (CR).
You may qualify if:
- Coronary Artery Disease (CAD) patients after myocardial infarction (STEMI/NSTEMI) and/or angioplasty and/or Percutaneous Coronary Intervention (PCI) and/or coronary artery bypass graft surgery who participate in phase II Cardiac Rehabilitation (CR).
You may not qualify if:
- Incapability to give informed consent
- Conditions that prevent patients from participation in CR including unstable coronary or cerebrovascular conditions and acute infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. Boris Schmitzlead
- European Commissioncollaborator
- University of Amsterdamcollaborator
- Technische Universität Dresdencollaborator
- MEDIZINISCHE UNIVERSITAT GRAZcollaborator
- Stichting Katholieke Universiteitcollaborator
- Foundation for Research and Technology - Hellascollaborator
Study Sites (1)
Klinik Königsfeld
Ennepetal, North Rhine-Westphalia, 58256, Germany
Related Publications (1)
Schmitz B, Wirtz S, Sestayo-Fernandez M, Schafer H, Douma ER, Alonso Vazquez M, Gonzalez-Salvado V, Habibovic M, Gatsios D, Kop WJ, Pena-Gil C, Mooren F. Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis. J Med Internet Res. 2024 Feb 22;26:e53991. doi: 10.2196/53991.
PMID: 38386376DERIVED
Biospecimen
Venous Blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Boris Schmitz, PhD
University of Witten/Herdecke, Dpt. Rehabilitation Sciences
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Primary Researcher Department of Rehabilitation Sciences
Study Record Dates
First Submitted
July 13, 2022
First Posted
July 18, 2022
Study Start
June 1, 2021
Primary Completion (Estimated)
August 31, 2029
Study Completion (Estimated)
August 31, 2029
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share